• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Preventing atherosclerotic events with aspirin.使用阿司匹林预防动脉粥样硬化事件。
BMJ. 2002 Jan 12;324(7329):103-5. doi: 10.1136/bmj.324.7329.103.
2
[Acetylsalicylic acid in the primary and secondary prevention of vascular disease].[乙酰水杨酸在血管疾病一级和二级预防中的应用]
Internist (Berl). 2010 Oct;51(10):1330, 1332. doi: 10.1007/s00108-010-2723-1.
3
Aspirin and the risk of hemorrhagic stroke.
J Fam Pract. 1999 Mar;48(3):169-70.
4
JAMA patient page. Aspirin therapy.《美国医学会杂志》患者专页。阿司匹林疗法。
JAMA. 2013 Apr 17;309(15):1645. doi: 10.1001/jama.2013.3866.
5
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.阿司匹林用于卒中及其他主要血管事件的一级预防：荟萃分析与假说
Arch Neurol. 2000 Mar;57(3):326-32. doi: 10.1001/archneur.57.3.326.
6
Aspirin and its rivals. As your options increase, your choices get harder.阿司匹林及其同类药物。随着选择增多，抉择愈发艰难。
Harv Mens Health Watch. 2002 Dec;7(5):1-5.
7
Aspirin for first-line heart attack prevention. These is still no consensus; the benefits must be weighed against the risks.
Duke Med Health News. 2014 Nov;20(11):5-6.
8
Aspirin and women--age matters. Aspirin can help healthy women over age 56 prevent both strokes and heart attacks. For younger women, the hazards of aspirin outweigh the benefits.
Harv Heart Lett. 2005 May;15(9):1-2.
9
Aspirin, myocardial infarction, and gastrointestinal bleeding.阿司匹林、心肌梗死与胃肠道出血。
Lancet. 1999 Feb 20;353(9153):676. doi: 10.1016/s0140-6736(05)75475-1.
10
Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
Health News. 2002 Nov;8(11):3.

引用本文的文献

1
Aspirin Use and Mortality in Two Contemporary US Cohorts.阿司匹林的使用与当代美国两个队列人群的死亡率。
Epidemiology. 2018 Jan;29(1):126-133. doi: 10.1097/EDE.0000000000000746.
2
Platelets: still a therapeutical target for haemostatic disorders.血小板：仍然是止血障碍的一个治疗靶点。
Int J Mol Sci. 2014 Oct 7;15(10):17901-19. doi: 10.3390/ijms151017901.
3
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial.低剂量阿司匹林与中老年人认知功能：随机对照试验
BMJ. 2008 Sep 1;337:a1198. doi: 10.1136/bmj.a1198.
4
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.糖尿病心血管并发症及事件的预防方法。
Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005.
5
Secondary prevention of stroke: a practical guide to drug treatment.中风的二级预防：药物治疗实用指南
CNS Drugs. 2004;18(4):221-41. doi: 10.2165/00023210-200418040-00003.
6
Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity.阿司匹林用于心血管疾病预防：上消化道及肾脏毒性的供应和管理成本
Br J Clin Pharmacol. 2004 Feb;57(2):188-98. doi: 10.1046/j.1365-2125.2003.01979.x.
7
Aspirin for the prevention of cardiovascular events in the elderly.阿司匹林用于预防老年人心血管事件。
Drugs Aging. 2003;20(13):999-1010. doi: 10.2165/00002512-200320130-00004.
8
Changes in drug treatment in the elderly between 1971 and 2000.1971年至2000年间老年人药物治疗的变化。
Eur J Clin Pharmacol. 2003 Nov;59(8-9):637-44. doi: 10.1007/s00228-003-0647-6. Epub 2003 Aug 16.
9
Acute coronary disease Athero-Inflammation: Therapeutic approach.急性冠状动脉疾病 动脉粥样硬化炎症：治疗方法
Thromb J. 2003 Jun 20;1(1):2. doi: 10.1186/1477-9560-1-2.
10
Antiplatelet therapy and atherosclerotic events. Commentary is inaccurate.抗血小板治疗与动脉粥样硬化事件。评论不准确。
BMJ. 2002 Apr 13;324(7342):917.

本文引用的文献

1
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.抗血小板治疗预防高危患者死亡、心肌梗死和中风的随机试验协作荟萃分析。
BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71.
2
Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
Curr Opin Nephrol Hypertens. 2001 Sep;10(5):625-31. doi: 10.1097/00041552-200109000-00012.
3
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.低剂量阿司匹林预防肺栓塞和深静脉血栓形成：肺栓塞预防（PEP）试验
Lancet. 2000 Apr 15;355(9212):1295-302.
4
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.消化性溃疡出血：辅助危险因素及与非甾体抗炎药的相互作用
Gut. 2000 Jan;46(1):27-31. doi: 10.1136/gut.46.1.27.
5
Anticoagulant and antiplatelet therapy in heart failure.心力衰竭中的抗凝和抗血小板治疗。
Curr Opin Cardiol. 1997 May;12(3):276-87. doi: 10.1097/00001573-199705000-00009.
6
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I：各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
7
Is aspirin safe for patients with heart failure?阿司匹林对心力衰竭患者是否安全？
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
8
The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.阿司匹林心肌梗死研究：最终结果。阿司匹林心肌梗死研究研究组。
Circulation. 1980 Dec;62(6 Pt 2):V79-84.
9
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation. 1980 Dec;62(6 Pt 2):V85-8.
10
The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.德奥阿司匹林试验：乙酰水杨酸、安慰剂和苯丙香豆素在心肌梗死二级预防中的比较。代表德奥研究小组。
Circulation. 1980 Dec;62(6 Pt 2):V63-72.

Preventing atherosclerotic events with aspirin.

作者信息

Cleland John G F

机构信息

Department of Cardiology, Castle Hill Hospital, University of Hull, Kingston upon Hull HU16 5JQ.

出版信息

BMJ. 2002 Jan 12;324(7329):103-5. doi: 10.1136/bmj.324.7329.103.

DOI:10.1136/bmj.324.7329.103
PMID:11786458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1121995/
Abstract
摘要